<?xml version="1.0" encoding="UTF-8"?>
<ref id="ref9">
 <mixed-citation publication-type="journal" id="cit9">
  <name>
   <surname>Le</surname>
   <given-names>T. T.</given-names>
  </name>; 
  <name>
   <surname>Andreadakis</surname>
   <given-names>Z.</given-names>
  </name>; 
  <name>
   <surname>Kumar</surname>
   <given-names>A.</given-names>
  </name>; 
  <name>
   <surname>Roman</surname>
   <given-names>R. G.</given-names>
  </name>; 
  <name>
   <surname>Tollefsen</surname>
   <given-names>S.</given-names>
  </name>; 
  <name>
   <surname>Saville</surname>
   <given-names>M.</given-names>
  </name>; 
  <name>
   <surname>Mayhew</surname>
   <given-names>S.</given-names>
  </name>
  <article-title>The COVID-19 Vaccine Development Landscape</article-title>. 
  <source>Nat. Rev. Drug Discovery</source>
  <year>2020</year>, 
  <volume>19</volume>, 
  <fpage>305</fpage>â€“
  <lpage>306</lpage>. 
  <pub-id pub-id-type="doi">10.1038/d41573-020-00073-5</pub-id>.
  <pub-id pub-id-type="pmid">32273591</pub-id>
 </mixed-citation>
</ref>
